No matches

Educational Resources

Beyond Itch: The Multifaceted Role of IL-4/IL-13 in the Pathogenesis of PN

Dermatology

11 min

expert video

The Shared Path: Type 2 Inflammation As a Driver of Chronic Itch

Dermatology

2 min

expert video

Understanding the Contribution of IL-4 in the Development of Fibrosis in Prurigo Nodularis

Dermatology

2 min

expert video

Beyond the Visible: The Cumulative Burden of Prurigo Nodularis

Dermatology

2 min

expert video

Beyond the Skin: Understanding Systemic Comorbidities in Prurigo Nodularis

Dermatology

2 min

expert video

Understanding the Full Scope of PN: Lesions, Dyspigmentation, and Patient Burden

Both Clinical and Subclinical Disease Control Are Important to Achieve Disease Modification in AD

Dermatology

5 min

expert video

Both Clinical and Subclinical Disease Control Are Important to Achieve Disease Modification in AD

Which Biomarkers of AD Might Be Robust Enough to Be Evaluated as a Measure of Disease Modification?

Dermatology

4 min

expert video

Which Biomarkers of AD Might Be Robust Enough to Be Evaluated as a Measure of Disease Modification?

Atopic Dermatitis and the Growing Evidence for Its Association with Various Non-Atopic Systemic Diseases

Dermatology

2 min

expert video

Atopic Dermatitis and the Growing Evidence for Its Association with Various Non-Atopic Systemic Diseases

Atopic Dermatitis and the Risk of Developing Other Atopic Diseases

Dermatology

3 min

expert video

Atopic Dermatitis and the Risk of Developing Other Atopic Diseases

Atopic and Nonatopic Comorbidities in AD and the Importance of Early Intervention

Dermatology

5 min

expert video

Atopic and Nonatopic Comorbidities in AD and the Importance of Early Intervention

Type 2 Cytokines Have Multiple Critical Roles in BP That Contribute to Inflammation and Itch

Dermatology

4 min

expert video

Type 2 Cytokines Have Multiple Critical Roles in BP That Contribute to Inflammation and Itch

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: Czech RepublicChange country/region